Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning (scientific article (publication date: 2002))

cites work (P2860)

Q24658236	14-3-3zeta mediates resistance of diffuse large B cell lymphoma to an anthracycline-based chemotherapeutic regimen
Q35141499	18F-fluorodeoxy-glucose positron emission tomography marks MYC-overexpressing human basal-like breast cancers
Q30616453	3D similarity-dissimilarity plot for high dimensional data visualization in the context of biomedical pattern classification
Q42960376	A Bayesian adaptive design with biomarkers for targeted therapies
Q47662298	A Bit-role for integrins in apoptosis
Q24797220	A DNA microarray survey of gene expression in normal human tissues
Q34347222	A Double Hit CD10-Negative B-Cell Lymphoma with t(3;8)(q27;q24) Leading to Juxtaposition of the BCL6 and MYC Loci Associated with Good Clinical Outcome.
Q34084858	A Novel Method of Amplification of FFPET-Derived RNA Enables Accurate Disease Classification with Microarrays
Q31150389	A Robust and Efficient Feature Selection Algorithm for Microarray Data
Q37416138	A classification framework applied to cancer gene expression profiles
Q24799711	A combinational feature selection and ensemble neural network method for classification of gene expression data
Q30920662	A comprehensive sensitivity analysis of microarray breast cancer classification under feature variability.
Q42254960	A computational study identifies HIV progression-related genes using mRMR and shortest path tracing
Q58420382	A conditional model of MLL-AF4 B-cell tumourigenesis using invertor technology
Q24653343	A cytomorphological and immunohistochemical profile of aggressive B-cell lymphoma: high clinical impact of a cumulative immunohistochemical outcome predictor score
Q37041909	A decade of genome-wide gene expression profiling in acute myeloid leukemia: flashback and prospects
Q33597519	A gene expression signature of CD34+ cells to predict major cytogenetic response in chronic-phase chronic myeloid leukemia patients treated with imatinib
Q24680233	A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma
Q33528306	A general co-expression network-based approach to gene expression analysis: comparison and applications
Q57739642	A graph clustering algorithm based on a clustering coefficient for weighted graphs
Q30000690	A graph-theoretic approach for identifying non-redundant and relevant gene markers from microarray data using multiobjective binary PSO
Q34173721	A hidden Markov model-based algorithm for identifying tumour subtype using array CGH data
Q57270609	A highly standardized, robust, and cost-effective method for genome-wide transcriptome analysis of peripheral blood applicable to large-scale clinical trials
Q30837821	A kernel-based multivariate feature selection method for microarray data classification
Q28283623	A microarray model system identifies potential new target genes of the proto-oncogene HOX11
Q24314955	A mitochondrial protein, Bit1, mediates apoptosis regulated by integrins and Groucho/TLE corepressors
Q37319182	A modified ant colony optimization algorithm for tumor marker gene selection
Q29614442	A molecular signature of metastasis in primary solid tumors
Q30574921	A new locally weighted K-means for cancer-aided microarray data analysis
Q33314438	A new method for class prediction based on signed-rank algorithms applied to Affymetrix microarray experiments
Q50605014	A novel algorithm for network-based prediction of cancer recurrence.
Q39550137	A novel bisindolymaleimide derivative (WK234) inhibits proliferation and induces apoptosis through the protein kinase Cβ pathway, in chronic myelogenous leukemia K562 cells
Q40415755	A novel diacylglycerol-lactone shows marked selectivity in vitro among C1 domains of protein kinase C (PKC) isoforms alpha and delta as well as selectivity for RasGRP compared with PKCalpha
Q61447948	A novel gene selection algorithm for cancer classification using microarray datasets
Q37148645	A novel information retrieval model for high-throughput molecular medicine modalities
Q58695388	A novel logistic regression model combining semi-supervised learning and active learning for disease classification
Q30991414	A novel sparse coding algorithm for classification of tumors based on gene expression data
Q100940737	A perspective on improving the R-CHOP regimen: from Mega-CHOP to ROBUST R-CHOP, the PHOENIX is yet to rise
Q36163040	A phase 2 trial of standard-dose cyclophosphamide, doxorubicin, vincristine, prednisone (CHOP) and rituximab plus bevacizumab for patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: SWOG 0515.
Q33384375	A phase I trial of enzastaurin in patients with recurrent gliomas
Q36495915	A phase II trial of single agent bevacizumab in patients with relapsed, aggressive non-Hodgkin lymphoma: Southwest oncology group study S0108.
Q27320446	A phosphodiesterase 4B-dependent interplay between tumor cells and the microenvironment regulates angiogenesis in B-cell lymphoma
Q35847673	A redox signature score identifies diffuse large B-cell lymphoma patients with a poor prognosis
Q98156925	A refined cell-of-origin classifier with targeted NGS and artificial intelligence shows robust predictive value in DLBCL
Q33915711	A robust approach based on Weibull distribution for clustering gene expression data.
Q33710489	A robust gene selection method for microarray-based cancer classification.
Q24319007	A short Nur77-derived peptide converts Bcl-2 from a protector to a killer
Q51584233	A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers.
Q31038369	A stable gene selection in microarray data analysis
Q33373556	A stable iterative method for refining discriminative gene clusters
Q28741787	A strategy for full interrogation of prognostic gene expression patterns: exploring the biology of diffuse large B cell lymphoma
Q24803210	A strategy for oligonucleotide microarray probe reduction
Q31026666	A survey of methods for classification of gene expression data using evolutionary algorithms
Q64994337	A systematic analysis of genomics-based modeling approaches for prediction of drug response to cytotoxic chemotherapies.
Q36519704	A tale of mice and (wo)men: development of and insights from an "all human" animal model of breast cancer metastasis to bone
Q34381620	AES/GRG5: more than just a dominant-negative TLE/GRG family member
Q53638690	AIDS and non-AIDS diffuse large B-cell lymphomas express different antigen profiles.
Q35073828	ATHENA: Identifying interactions between different levels of genomic data associated with cancer clinical outcomes using grammatical evolution neural network
Q51911790	Absence of cyclin-D2 and Bcl-2 expression within the germinal centre type of diffuse large B-cell lymphoma identifies a very good prognostic subgroup of patients.
Q43433389	Absolute monocyte/lymphocyte count prognostic score is independent of immunohistochemically determined cell of origin in predicting survival in diffuse large B-cell lymphoma
Q35023886	Accurate classification of diffuse large B-cell lymphoma into germinal center and activated B-cell subtypes using a nuclease protection assay on formalin-fixed, paraffin-embedded tissues
Q36242926	Activation of the mTOR Pathway by Oxaliplatin in the Treatment of Colorectal Cancer Liver Metastasis.
Q44509220	Activity of a novel anti-folate (PDX, 10-propargyl 10-deazaaminopterin) against human lymphoma is superior to methotrexate and correlates with tumor RFC-1 gene expression.
Q33311480	Adipose gene expression prior to weight loss can differentiate and weakly predict dietary responders.
Q38806478	Adolescent and young adult non-Hodgkin lymphoma.
Q36973076	Advances in cancer tissue microarray technology: Towards improved understanding and diagnostics
Q31130057	Advances in quantitative proteomics using stable isotope tags
Q35551113	Advantages and limitations of microarray technology in human cancer
Q36048644	Aggressive B-cell lymphomas: a review based on the workshop of the XI Meeting of the European Association for Haematopathology.
Q57716903	An Aggregated Cross-Validation Framework for Computational Discovery of Disease-Associative Genes
Q91825721	An Efficient hybrid filter-wrapper metaheuristic-based gene selection method for high dimensional datasets
Q59121715	An Improved Fuzzy Based Missing Value Estimation in DNA Microarray Validated by Gene Ranking
Q33613086	An algorithm for classifying tumors based on genomic aberrations and selecting representative tumor models
Q35096060	An anti-apoptotic role for galectin-3 in diffuse large B-cell lymphomas
Q33449331	An empirical study of univariate and genetic algorithm-based feature selection in binary classification with microarray data.
Q41127479	An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era
Q34585980	An extension of PPLS-DA for classification and comparison to ordinary PLS-DA
Q47151590	An inflammation-based cumulative prognostic score system in patients with diffuse large B cell lymphoma in rituximab era.
Q30574057	An integrated approach for identifying wrongly labelled samples when performing classification in microarray data
Q33226881	An integrated feature selection and classification method to select minimum number of variables on the case study of gene expression data
Q33495831	Analysis of DNA microarray expression data
Q41566129	Analysis of differential gene expression in colorectal cancer and stroma using fluorescence-activated cell sorting purification
Q38495647	Analysis of the gene expression profile of curcumin-treated kidney on endotoxin-induced renal inflammation
Q30696568	Analyzing array data using supervised methods.
Q35069714	Analyzing kernel matrices for the identification of differentially expressed genes
Q37321798	Angiogenesis and antiangiogenic therapy in non-Hodgkin's lymphoma
Q33623874	Anomalous constitutive Src kinase activity promotes B lymphoma survival and growth
Q48222343	Anti-CD22 and anti-CD79B antibody drug conjugates are active in different molecular diffuse large B-cell lymphoma subtypes.
Q34144940	Anti-CD47 antibody synergizes with rituximab to promote phagocytosis and eradicate non-Hodgkin lymphoma
Q37000598	Antimicrobial Resistance Prediction in PATRIC and RAST.
Q36484693	Apoptosis resistance and response to chemotherapy in primary nodal diffuse large B-cell lymphoma
Q39601989	Apoptotic induction in B-cell acute lymphoblastic leukemia cell lines treated with a protein kinase Cβ inhibitor
Q30946829	Application of Bayesian logistic regression to mining biomedical data
Q33974282	Application of an efficient Bayesian discretization method to biomedical data
Q30671533	Application of machine learning algorithms for clinical predictive modeling: a data-mining approach in SCT.
Q34759491	Application of toxicogenomics to drug development
Q37409174	Applications of Bayesian gene selection and classification with mixtures of generalized singular g-priors
Q37175004	Applications of machine learning in cancer prediction and prognosis
Q35649312	Applications of microarrays to histopathology
Q29622827	Applying the principles of stem-cell biology to cancer
Q24597424	Are we ready to stratify treatment for diffuse large B-cell lymphoma using molecular hallmarks?
Q41808692	Array comparative genomic hybridization reveals genomic copy number changes associated with outcome in diffuse large B-cell lymphomas
Q57261270	Array for cancer prognostics
Q37976288	Array-based pharmacogenomics of molecular-targeted therapies in oncology.
Q89539949	Artificial Intelligence in Nephrology: How Can Artificial Intelligence Augment Nephrologists' Intelligence?
Q89741191	Artificial intelligence in sleep medicine: Background and implications for clinicians
Q33850118	Assessment of fine needle aspiration feasibility and specimen adequacy for molecular diagnostics of benign vocal fold lesions
Q30882805	AucPR: an AUC-based approach using penalized regression for disease prediction with high-dimensional omics data
Q31147890	Automated Detection of Cancer Associated Genes Using a Combined Fuzzy-Rough-Set-Based F-Information and Water Swirl Algorithm of Human Gene Expression Data
Q35622991	B lymphoid neoplasms of mice: characteristics of naturally occurring and engineered diseases and relationships to human disorders
Q38887855	B-cell precursor acute lymphoblastic leukemia and stromal cells communicate through Galectin-3.
Q30689368	Bayesian hierarchical clustering for studying cancer gene expression data with unknown statistics
Q30982894	Bayesian model averaging: development of an improved multi-class, gene selection and classification tool for microarray data
Q33524687	Bayesian rule learning for biomedical data mining
Q53534114	Bcl-6 and c-Myc are rarely co-expressed in adult diffuse large B-cell lymphoma.
Q36139880	Best Practice No 185. Cytological and molecular diagnosis of lymphoma
Q40654287	Beta-2 microglobulin as a significant prognostic factor and a new risk model for patients with diffuse large B-cell lymphoma.
Q33408536	Bevacizumab and cyclosphosphamide, doxorubicin, vincristine and prednisone in combination for patients with peripheral T-cell or natural killer cell neoplasms: an Eastern Cooperative Oncology Group study (E2404).
Q37738558	Beyond R-CHOP and the IPI in large-cell lymphoma: molecular markers as an opportunity for stratification
Q38279648	Bias-corrected diagonal discriminant rules for high-dimensional classification.
Q47378712	Biology Informs Treatment Choices in Diffuse Large B Cell Lymphoma
Q33373584	Biomarker discovery across annotated and unannotated microarray datasets using semi-supervised learning
Q60047428	Biomarkers of erosive arthritis in systemic lupus erythematosus: Application of machine learning models
Q36338329	Biomarkers of potential prognostic significance in diffuse large B-cell lymphoma
Q26995189	Bit1 in anoikis resistance and tumor metastasis
Q37375767	Block-diagonal discriminant analysis and its bias-corrected rules.
Q37451562	Blood-based transcriptomics: leukemias and beyond
Q35782196	Boosting for high-dimensional two-class prediction
Q35083387	Building an outcome predictor model for diffuse large B-cell lymphoma
Q34696338	Burkitt's and Burkitt-like lymphoma.
Q31014129	CAMUR: Knowledge extraction from RNA-seq cancer data through equivalent classification rules
Q36470314	CCL3 and CCL4 are biomarkers for B cell receptor pathway activation and prognostic serum markers in diffuse large B cell lymphoma
Q41993390	CD81 protein is expressed at high levels in normal germinal center B cells and in subtypes of human lymphomas
Q28744449	CaGrid Workflow Toolkit: a Taverna based workflow tool for cancer grid
Q55116691	Cancer Characteristic Gene Selection via Sample Learning Based on Deep Sparse Filtering.
Q35024666	Cancer diagnosis and microarrays
Q37196999	Canine lymphoma as a comparative model for human non-Hodgkin lymphoma: recent progress and applications
Q37259663	Cell cycle and apoptosis regulatory protein (CARP)-1 is a novel, adriamycin-inducible, diffuse large B-cell lymphoma (DLBL) growth suppressor
Q44576174	Characteristics and prognostic factors for head and neck non-Hodgkin's lymphoma in Chinese patients
Q35906972	Characterization of an oxaliplatin sensitivity predictor in a preclinical murine model of colorectal cancer.
Q40577309	Characterization of expression of protein kinase C isozymes in human B-cell lymphoma: Relationship between its expression and prognosis
Q51593313	Characterization of gene expression profiles of T cells during anti-tumor response.
Q35062461	Chemotherapy response and resistance
Q35610374	Chromosomal instability as a prognostic marker in cervical cancer
Q59401466	Class distinction between follicular adenomas and follicular carcinomas of the thyroid gland on the basis of their signature expression
Q33723485	Class prediction for high-dimensional class-imbalanced data
Q33579530	Class prediction models of thrombocytosis using genetic biomarkers
Q35204067	Class struggle: expression profiling and categorizing cancer
Q26822875	Class-imbalanced classifiers for high-dimensional data
Q35543906	Classification of bladder cancer by microarray expression profiling: towards a general clinical use of microarrays in cancer diagnostics
Q35062466	Classification of cancers by expression profiling
Q45961973	Classification of large microarray datasets using fast random forest construction.
Q33386690	Classification of lymphoid neoplasms: the microscope as a tool for disease discovery
Q40552431	Classification systems for acute and chronic leukaemias
Q35043749	Classifying human cancer by analysis of gene expression
Q35053072	Clear cell variant of diffuse large B-cell lymphoma: a case report
Q40983028	Clinical Significance of TIPE2 Protein Upregulation in Non-Hodgkin's Lymphoma
Q53161291	Clinical and prognostic significance of apoptotic profile in patients with newly diagnosed nodal diffuse large B-cell lymphoma (DLBCL).
Q40039687	Clinical application of modified bag-of-features coupled with hybrid neural-based classifier in dengue fever classification using gene expression data
Q35122245	Clinical applications of molecular genetic testing in hematologic malignancies: Advantages and limitations
Q35167912	Clinical biomarkers in drug discovery and development
Q39861902	Clinical significance of co-expression of CD21 and LFA-1 in B-cell lymphoma
Q86988633	Clinically important variants of diffuse large B-cell lymphoma
Q27496523	Clustering cancer gene expression data: a comparative study
Q30577913	Clustering gene expression data using a diffraction-inspired framework
Q30936126	Coexpression analysis of human genes across many microarray data sets
Q47136273	Collaborative representation-based classification of microarray gene expression data
Q30983533	Collateral missing value imputation: a new robust missing value estimation algorithm for microarray data
Q64254427	Combination of Enzastaurin and Ibrutinib synergistically induces anti-tumor effects in diffuse large B cell lymphoma
Q37175934	Combining clinical and genomic covariates via Cov-TGDR
Q41288830	Combining dissimilarities in a Hyper Reproducing Kernel Hilbert Space for complex human cancer prediction
Q40552437	Comments on the 2001 WHO proposal for the classification of haematopoietic neoplasms
Q33375877	Comparative optimism in models involving both classical clinical and gene expression information.
Q31050008	Comparison and evaluation of methods for generating differentially expressed gene lists from microarray data.
Q53792133	Comparison of different isolation techniques prior gene expression profiling of blood derived cells: impact on physiological responses, on overall expression and the role of different cell types.
Q40635674	Comparison of gene expression profiles of lymphoma cell lines from transformed follicular lymphoma, Burkitt's lymphoma and de novo diffuse large B-cell lymphoma
Q33647460	Comparison study of microarray meta-analysis methods.
Q55383227	Comprehensive analysis of differentially expressed profiles of lncRNAs and mRNAs reveals ceRNA networks in the transformation of diffuse large B-cell lymphoma.
Q40521338	Computing molecular signatures as optima of a bi-objective function: method and application to prediction in oncogenomics.
Q35740025	Constitutive activation of the DNA damage response pathway as a novel therapeutic target in diffuse large B-cell lymphoma
Q89530487	Constraining classifiers in molecular analysis: invariance and robustness
Q41974323	Construction and analysis of tree models for chromosomal classification of diffuse large B-cell lymphomas
Q28246420	Conversion of Bcl-2 from protector to killer by interaction with nuclear orphan receptor Nur77/TR3
Q36350416	Coordinated loss of microRNA group causes defenseless signaling in malignant lymphoma.
Q42243553	Copy number abnormalities, MYC activity, and the genetic fingerprint of normal B cells mechanistically define the microRNA profile of diffuse large B-cell lymphoma
Q46901584	Correlations of mRNA expression and in vitro chemosensitivity to enzastaurin in freshly explanted human tumor cells
Q110949539	Cost-sensitive learning strategies for high-dimensional and imbalanced data: a comparative study
Q33591022	Covariance-regularized regression and classification for high-dimensional problems
Q37132882	Cross-platform assessment of genomic imbalance confirms the clinical relevance of genomic complexity and reveals loci with potential pathogenic roles in diffuse large B-cell lymphoma
Q35188471	Current and potential uses for DNA microarrays in transplantation medicine: lessons from other disciplines.
Q33635353	Current gene expression studies in esophageal carcinoma
Q36637900	Current insights into the regulation of programmed cell death by NF-kappaB.
Q35545076	Current trends in large cell lymphoma
Q36334968	Cyclic nucleotide phosphodiesterases as targets for treatment of haematological malignancies
Q81006773	Cytogenetic features of de novo CD5-positive diffuse large B-cell lymphoma: chromosome aberrations affecting 8p21 and 11q13 constitute major subgroups with different overall survival
Q53203539	DLBCL awareness.
Q35995077	DNA array-based gene profiling: from surgical specimen to the molecular portrait of cancer
Q38335184	DNA microarray allows molecular profiling of rheumatoid arthritis and identification of pathophysiological targets.
Q52011373	DNA microarrays: vital statistics.
Q33449315	Data perturbation independent diagnosis and validation of breast cancer subtypes using clustering and patterns
Q33629575	De novo CD5 positive diffuse large B-cell lymphomas with bone marrow involvement in Korean
Q35060298	Defining aggressive prostate cancer using a 12-gene model
Q37121717	Del(6)(q22) and BCL6 rearrangements in primary CNS lymphoma are indicators of an aggressive clinical course
Q35119804	Deregulation of COMMD1 is associated with poor prognosis in diffuse large B-cell lymphoma
Q35870285	Detection of protein tyrosine-kinase (PTK) gene expression pattern in normal and malignant T lymphocytes by combined PTK-specific polymerase chain reaction and parallel denaturing gradient gel electrophoresis
Q28543490	Development and blind clinical validation of a microRNA based predictor of response to treatment with R-CHO(E)P in DLBCL
Q92757544	Development of a Reproducible Prognostic Gene Signature to Predict the Clinical Outcome in Patients with Diffuse Large B-Cell Lymphoma
Q36734636	Development of a clinically feasible molecular assay to predict recurrence of stage II colon cancer
Q37257101	Development of a malignancy-associated proteomic signature for diffuse large B-cell lymphoma
Q28731283	Development of multigene expression signature maps at the protein level from digitized immunohistochemistry slides
Q30883005	Diagnostic and prognostic prediction using gene expression profiles in high-dimensional microarray data
Q34182374	Differences and similarities in the transcriptional profile of peripheral whole blood in early and late-onset preeclampsia: insights into the molecular basis of the phenotype of preeclampsiaa
Q34671919	Differential display in the time of microarrays
Q52009281	Differential gene expression in non-malignant tumour microenvironment is associated with outcome in follicular lymphoma patients treated with rituximab and CHOP.
Q54575989	Differential gene expression profiling of vocal fold polyps and Reinke's edema by complementary DNA microarray.
Q36673781	Differential gene-expression profiles associated with gastric adenoma
Q37045955	Diffuse large B cell lymphoma: from gene expression profiling to prediction of outcome
Q38053983	Diffuse large B cell lymphoma: molecular targeted therapy
Q33846801	Diffuse large B cell lymphoma: using pathologic and molecular biomarkers to define subgroups for novel therapy.
Q79711344	Diffuse large B-cell lymphoma
Q36622610	Diffuse large B-cell lymphoma: a heterogeneous group of non-Hodgkin lymphomas comprising several distinct clinicopathological entities
Q33622342	Diffuse large B-cell lymphoma: can genomics improve treatment options for a curable cancer?
Q35140193	Diffuse large B-cell lymphoma: insights gained from gene expression profiling
Q53005363	Diffuse large B-cell lymphoma: sites of extranodal involvement are a stronger prognostic indicator than number of extranodal sites in the rituximab era.
Q79898544	Diffuse large B-cell lymphomas with germinal center B-cell-like differentiation immunophenotypic profile are associated with high apoptotic index, high expression of the proapoptotic proteins bax, bak and bid and low expression of the antiapoptotic
Q33168184	Diffuse large B-cell non-Hodgkin lymphoma involving the unilateral carotid space in an elderly man: A case report
Q36089234	Discovering Pair-wise Synergies in Microarray Data
Q28539530	Discovering hidden connections among diseases, genes and drugs based on microarray expression profiles with negative-term filtering
Q33858819	Discriminating lymphomas and reactive lymphadenopathy in lymph node biopsies by gene expression profiling
Q92356484	Disruption of the Myc-PDE4B regulatory circuitry impairs B-cell lymphoma survival
Q35754783	Distinct and complementary information provided by use of tissue and DNA microarrays in the study of breast tumor markers
Q54695946	Distinct pattern of gene expression in pyothorax-associated lymphoma (PAL), a lymphoma developing in long-standing inflammation.
Q40612687	Divergent C-terminal transactivation domains of Rel/NF-kappa B proteins are critical determinants of their oncogenic potential in lymphocytes
Q90320483	Double-Hit Gene Expression Signature Defines a Distinct Subgroup of Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma
Q38508045	Dynamically weighted clustering with noise set.
Q33673921	E mu-BRD2 transgenic mice develop B-cell lymphoma and leukemia.
Q39324849	ESMO consensus conference on malignant lymphoma: general perspectives and recommendations for prognostic tools in mature B-cell lymphomas and chronic lymphocytic leukaemia
Q34995135	Economics and quality of care for patients with acute coronary syndromes: the impending crisis
Q39729652	Effects of enzastaurin, alone or in combination, on signaling pathway controlling growth and survival of B-cell lymphoma cell lines
Q33413210	Efficacy and safety of lenalinomide combined with rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma
Q34192330	Efficacy of the multi-kinase inhibitor enzastaurin is dependent on cellular signaling context
Q38774866	Elevated RNA expression of long non‑coding HOTAIR promotes cell proliferation and predicts a poor prognosis in patients with diffuse large B cell lymphoma
Q44454015	Elevated serum endostatin is associated with poor outcome in patients with non-Hodgkin lymphoma
Q54474262	Ellagic acid checks lymphoma promotion via regulation of PKC signaling pathway.
Q33264816	Elucidation of a protein signature discriminating six common types of adenocarcinoma
Q83381745	Emerging Therapeutic Targets in Diffuse Large B-Cell Lymphoma
Q37598947	Emerging therapies for B-cell non-Hodgkin lymphoma
Q24811855	Enhanced microarray performance using low complexity representations of the transcriptome
Q27851721	Enzastaurin has anti-tumour effects in lung cancers with overexpressed JAK pathway molecules
Q37884624	Enzastaurin hydrochloride for lymphoma: reassessing the results of clinical trials in light of recent advances in the biology of B-cell malignancies
Q39663655	Enzastaurin inhibits invasion and metastasis in lung cancer by diverse molecules
Q40848674	Escaping the cut by restriction enzymes through single-strand self-annealing of host-edited 12-bp and longer synthetic palindromes
Q44249820	Essential role of caveolae in interleukin-6- and insulin-like growth factor I-triggered Akt-1-mediated survival of multiple myeloma cells
Q30978092	Evaluating methods for classifying expression data
Q53388123	Evolving-Pattern Analysis of Transient and Long-Term Biomarkers for Cancers: Hepatocellular Carcinoma as a Case.
Q53615601	Evolving-pattern analysis of transient and long-term biomarkers for cancers: Hepatocellular carcinoma as a case.
Q51967988	Experimental trial for diagnosis of pancreatic ductal carcinoma based on gene expression profiles of pancreatic ductal cells.
Q73314540	Exploring Primary Cutaneous B-Cell Lymphoma by Microarray Technology
Q33859180	Exploring the within- and between-class correlation distributions for tumor classification
Q52565931	Expression and prognostic implications of cell cycle regulatory molecules, p16, p21, p27, p14 and p53 in germinal centre and non-germinal centre B-like diffuse large B-cell lymphomas.
Q33209668	Expression genomics and cancer biology
Q54644145	Expression of C-IAP1, C-IAP2 and SURVIVIN discriminates different types of lymphoid malignancies.
Q36865089	Expression of DBC1 and Androgen Receptor Predict Poor Prognosis in Diffuse Large B Cell Lymphoma
Q80670802	Expression of HGAL in primary cutaneous large B-cell lymphomas: evidence for germinal center derivation of primary cutaneous follicular lymphoma
Q63633924	Expression of PD-1 (CD279) and FoxP3 in diffuse large B-cell lymphoma
Q81791444	Expression of PKC-beta or cyclin D2 predicts for inferior survival in diffuse large B-cell lymphoma
Q46724259	Expression of TNF-receptor associated factor 2 correlates with poor progression-free survival time in ABC-like primary nodal diffuse large B-cell lymphomas
Q54602143	Expression of ice, bcl-2, c-myc and p53 in different bone marrow cell populations from patients with diffuse large B-cell lymphoma.
Q25256909	Expression of minichromosome maintenance protein 2 as a marker for proliferation and prognosis in diffuse large B-cell lymphoma: a tissue microarray and clinico-pathological analysis.
Q44655400	Expression of nm23‐H1 is associated with poor prognosis in peripheral T‐cell lymphoma
Q46955817	Expression of the bcl-6 and MUM1/IRF4 proteins correlate with overall and disease-specific survival in patients with primary cutaneous large B-cell lymphoma: a tissue microarray study
Q42538635	Expression of the human germinal center-associated lymphoma (HGAL) protein, a new marker of germinal center B-cell derivation
Q35770767	Expression of the polycomb-group gene BMI1 is related to an unfavourable prognosis in primary nodal DLBCL.
Q57636725	Expression profile of translation initiation factor eIF2B5 in diffuse large B-cell lymphoma and its correlation to clinical outcome
Q40631853	Expression profiling targeting chromosomes for tumor classification and prediction of clinical behavior.
Q33378247	Expression-based Pathway Signature Analysis (EPSA): mining publicly available microarray data for insight into human disease
Q30824314	Extending the utility of gene profiling data by bridging microarray platforms.
Q36558024	Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy
Q53515118	FDG-PET after 1 cycle of therapy predicts outcome in diffuse large cell lymphoma and classic Hodgkin disease.
Q36871999	FOXP1: a potential therapeutic target in cancer.
Q47606657	Factors predicting long-term survival in low-risk diffuse large B-cell lymphoma
Q46957617	Fas and Fas ligand expression on germinal center type-diffuse large B-cell lymphoma is associated with the clinical outcome
Q36005212	Feature Selection and Cancer Classification via Sparse Logistic Regression with the Hybrid L1/2 +2 Regularization
Q35756955	Feature selection and molecular classification of cancer using genetic programming
Q58101114	Feature selection of gene expression data for Cancer classification using double RBF-kernels
Q30478162	Feature selection using Haar wavelet power spectrum
Q33526505	FiGS: a filter-based gene selection workbench for microarray data
Q39328378	Finding a helix in a haystack: nucleic acid cytometry with droplet microfluidics
Q34351520	Finding minimum gene subsets with heuristic breadth-first search algorithm for robust tumor classification
Q35240801	Finding top-k covering irreducible contrast sequence rules for disease diagnosis.
Q35008948	Focus on lymphomas
Q41887389	Fold change rank ordering statistics: a new method for detecting differentially expressed genes.
Q35073307	From microarrays to new therapeutic approaches in bladder cancer.
Q30749843	From patterns to pathways: gene expression data analysis comes of age.
Q37136999	Front-line therapy for nonlocalized diffuse large B-cell lymphoma: what has been demonstrated and what is yet to be established.
Q36192439	Frontline rituximab, cyclophosphamide, doxorubicin, and prednisone with bortezomib (VR-CAP) or vincristine (R-CHOP) for non-GCB DLBCL.
Q36150368	Functional genomic analysis of cancer metastasis: biologic insights and clinical implications
Q39420364	Functional networks inference from rule-based machine learning models.
Q42637800	Functional signatures identified in B-cell non-Hodgkin lymphoma profiles.
Q52027273	Fuzzy neural network applied to gene expression profiling for predicting the prognosis of diffuse large B-cell lymphoma.
Q53508384	Ga-67 SPECT: ave atque vale! Or have we bid a premature farewell to a trusted friend?
Q38354055	Gain-of-function mutations and copy number increases of Notch2 in diffuse large B-cell lymphoma
Q36440083	Galectin-3 binds to CD45 on diffuse large B-cell lymphoma cells to regulate susceptibility to cell death
Q33561477	Gene Feature Extraction Based on Nonnegative Dual Graph Regularized Latent Low-Rank Representation
Q37738446	Gene arrays in lymphoma: Where will they fit in?
Q26825706	Gene expression analysis in RA: towards personalized medicine
Q36673583	Gene expression array profile of human osteosarcoma
Q33381434	Gene expression data classification using consensus independent component analysis
Q30724775	Gene expression in cancer: the application of microarrays
Q46042728	Gene expression patterns in AIDS versus non-AIDS-related diffuse large B-cell lymphoma
Q38354504	Gene expression phenotypic models that predict the activity of oncogenic pathways
Q42432005	Gene expression predicts overall survival in paraffin-embedded tissues of diffuse large B-cell lymphoma treated with R-CHOP.
Q35661018	Gene expression profiling and its application in studies of haematological malignancy.
Q38519535	Gene expression profiling identifies molecular subgroups among nodal peripheral T-cell lymphomas.
Q37074127	Gene expression profiling in autoimmune noninfectious uveitis disease
Q36799850	Gene expression profiling in diffuse large B-cell lymphoma
Q38513479	Gene expression profiling of diffuse large B-cell lymphoma supervised by CD21 expression
Q36613726	Gene expression profiling of primary cultures of ovarian epithelial cells identifies novel molecular classifiers of ovarian cancer.
Q77856791	Gene expression profiling to predict lymphoma outcome
Q36050530	Gene expression profiling using RNA extracted from whole blood: technologies and clinical applications
Q104795172	Gene expression profiling-based risk prediction and profiles of immune infiltration in diffuse large B-cell lymphoma
Q35758712	Gene expression profiling: from microarrays to medicine.
Q35573313	Gene expression profiling: will it complement or replace immunophenotyping?
Q36568849	Gene expression signatures and outcome prediction in mature B-cell malignancies
Q44828229	Gene expression signatures in lymphoid tumours
Q36678558	Gene expression-based screening for inhibitors of PDGFR signaling
Q30584472	Gene selection and cancer type classification of diffuse large-B-cell lymphoma using a bivariate mixture model for two-species data
Q34173671	Gene selection and classification for cancer microarray data based on machine learning and similarity measures
Q36100658	Gene selection for cancer classification with the help of bees
Q31132175	Gene selection for classification of microarray data based on the Bayes error
Q35208950	Gene selection for multiclass prediction by weighted Fisher criterion
Q30807880	Gene selection in microarray data: the elephant, the blind men and our algorithms
Q36295294	Gene set enrichment analysis unveils the mechanism for the phosphodiesterase 4B control of glucocorticoid response in B-cell lymphoma
Q35146553	Gene-expression profiling in human cutaneous melanoma
Q36690245	Gene-expression signatures in oncology diagnostics
Q28276837	Genes associated with the tumour microenvironment are differentially expressed in cured versus primary chemotherapy-refractory diffuse large B-cell lymphoma
Q24798750	Genetic alteration and gene expression modulation during cancer progression
Q35985492	Genomic and proteomic approaches for studying human cancer: prospects for true patient-tailored therapy
Q37363928	Genomic and proteomic biomarkers for cancer: a multitude of opportunities.
Q37406963	Genomic approaches to small molecule discovery
Q38042513	Genomic profiling using array comparative genomic hybridization define distinct subtypes of diffuse large B-cell lymphoma: a review of the literature
Q36303896	Genomics in breast cancer-therapeutic implications
Q40949651	Genotyping on a thermal gradient DNA chip
Q43137033	Germinal center B cell-like (GCB) and activated B cell-like (ABC) type of diffuse large B cell lymphoma (DLBCL): analysis of molecular predictors, signatures, cell cycle state and patient survival.
Q35121615	Global Gene Expression Profiling in the Study of Multiple Myeloma
Q80265745	Global gene expression profiling of formalin-fixed paraffin-embedded tumor samples: a comparison to snap-frozen material using oligonucleotide microarrays
Q34276961	Google goes cancer: improving outcome prediction for cancer patients by network-based ranking of marker genes
Q93012478	Guidelines for using sigQC for systematic evaluation of gene signatures
Q35206356	HLA class II antibodies in the treatment of hematologic malignancies
Q91949197	Hellinger distance-based stable sparse feature selection for high-dimensional class-imbalanced data
Q38433314	Heterogeneity of protein kinase C beta(2) expression in lymphoid malignancies
Q53662425	High Ki-67 expression in involved bone marrow predicts worse clinical outcome in diffuse large B cell lymphoma patients treated with R-CHOP therapy.
Q28206624	High level of cannabinoid receptor 1, absence of regulator of G protein signalling 13 and differential expression of Cyclin D1 in mantle cell lymphoma
Q37335051	High resolution array comparative genomic hybridization identifies copy number alterations in diffuse large B-cell lymphoma that predict response to immuno-chemotherapy
Q83820573	High throughput tissue microarray analysis of FHIT expression in diffuse large cell B-cell lymphoma from Saudi Arabia
Q28740452	High-dimensional pharmacogenetic prediction of a continuous trait using machine learning techniques with application to warfarin dose prediction in African Americans
Q58908211	High-dose chemotherapy with autologous stem cell support for first-line treatment of aggressive non-Hodgkin lymphoma: a systematic review and meta-analysis based on individual patient data
Q50485002	High-resolution loss of heterozygosity screening implicates PTPRJ as a potential tumor suppressor gene that affects susceptibility to Non-Hodgkin's lymphoma.
Q45899999	Higher response to lenalidomide in relapsed/refractory diffuse large B-cell lymphoma in nongerminal center B-cell-like than in germinal center B-cell-like phenotype.
Q53437646	History of haematopoietic stem-cell transplantation.
Q43011229	How do we define Hodgkin's disease? The authors' reply
Q64121066	I-Boost: an integrative boosting approach for predicting survival time with multiple genomics platforms
Q40614440	INCORPORATING BIOLOGICAL INFORMATION INTO LINEAR MODELS: A BAYESIAN APPROACH TO THE SELECTION OF PATHWAYS AND GENES.
Q78427251	Identification and validation of seven genes, as potential markers, for the differential diagnosis of small B cell lymphomas (small lymphocytic lymphoma, marginal zone B cell lymphoma and mantle cell lymphoma) by cDNA macroarrays analysis
Q92628694	Identification of CD4+ T cell biomarkers for predicting the response of patients with relapsing‑remitting multiple sclerosis to natalizumab treatment
Q37661495	Identification of Marker Genes for Cancer Based on Microarrays Using a Computational Biology Approach.
Q31109027	Identification of a robust gene signature that predicts breast cancer outcome in independent data sets
Q35018604	Identification of candidate B-lymphoma genes by cross-species gene expression profiling
Q43766905	Identification of differentially expressed proteins in chemotherapy-sensitive and chemotherapy-resistant diffuse large B cell lymphoma by proteomic methods
Q24791397	Identification of expressed genes linked to malignancy of human colorectal carcinoma by parametric clustering of quantitative expression data
Q76312993	Identification of genes whose expression patterns differ in benign lymphoid tissue and follicular, mantle cell, and small lymphocytic lymphoma
Q41365240	Identification of key lncRNAs in colorectal cancer progression based on associated protein-protein interaction analysis
Q36047432	Identification of metastasis-suppressive microRNAs in primary melanoma
Q48332534	Identification of molecular subtypes of glioblastoma by gene expression profiling
Q93079390	Identifying Methylation Pattern and Genes Associated with Breast Cancer Subtypes
Q52111529	Identifying distinct classes of bladder carcinoma using microarrays.
Q89811270	Identifying transcriptional profiles and evaluating prognostic biomarkers of HIV-associated diffuse large B-cell lymphoma from Malawi
Q28536423	Immune response to combination therapy for non-Hodgkin lymphomas
Q33700531	Immunohistochemical and molecular characteristics with prognostic significance in diffuse large B-cell lymphoma
Q51514379	Immunohistochemical detection of MYC protein correlates with MYC gene status in aggressive B cell lymphomas.
Q80270939	Immunohistochemical detection of protein kinase C-beta (PKC-beta) in tumour specimens of patients with non-small cell lung cancer
Q45372503	Immunohistochemical expression profile and prognosis in patients with diffuse large B-cell lymphoma with or without human immunodeficiency virus infection
Q44813152	Immunohistochemical profile and prognostic significance in primary central nervous system lymphoma: Analysis of 89 cases
Q33561185	Immunophenotypic analysis of AIDS-related diffuse large B-cell lymphoma and clinical implications in patients from AIDS Malignancies Consortium clinical trials 010 and 034
Q60548642	Impact of ecological redundancy on the performance of machine learning classifiers in vegetation mapping
Q37831960	Impact of gene expression profiling in lymphoma diagnosis and prognosis.
Q35806762	Impact of microarray technology in clinical oncology
Q53112598	Impact of occult bone marrow involvement on the outcome of rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisone therapy for diffuse large B-cell lymphoma.
Q57174076	Implications of STAT3 and STAT5 signaling on gene regulation and chromatin remodeling in hematopoietic cancer
Q31105470	Importance of data structure in comparing two dimension reduction methods for classification of microarray gene expression data
Q34475554	Improving accuracy for cancer classification with a new algorithm for genes selection
Q33784190	Improving cancer classification accuracy using gene pairs
Q39841564	In Vivo Measurements of Tumor Metabolism and Growth after Administration of Enzastaurin Using Small Animal FDG Positron Emission Tomography
Q33701036	In silico analyses reveal common cellular pathways affected by loss of heterozygosity (LOH) events in the lymphomagenesis of Non-Hodgkin's lymphoma (NHL).
Q81413385	Incidence of diffuse large B-cell lymphoma of germinal center B-cell origin in whole diffuse large B-cell lymphoma: tissue fluorescence in situ hybridization using t(14;18) compared with immunohistochemistry
Q104795127	Incidence of relapsed/refractory diffuse large B-cell lymphoma (DLBCL) including CNS relapse in a population-based cohort of 4243 patients in Sweden
Q33800442	Increased MYC gene copy number correlates with increased mRNA levels in diffuse large B-cell lymphoma
Q31041309	Independent component analysis-based penalized discriminant method for tumor classification using gene expression data
Q36318541	Individualised cancer therapeutics: dream or reality?
Q44898962	Infused CD34 cell dose, but not tumour cell content of peripheral blood progenitor cell grafts, predicts clinical outcome in patients with diffuse large B-cell lymphoma and follicular lymphoma grade 3 treated with high-dose therapy
Q44349388	Inhibition of FLT3 in MLL. Validation of a therapeutic target identified by gene expression based classification
Q34860750	Inhibition of bromodomain proteins for the treatment of human diffuse large B-cell lymphoma.
Q35670308	Inhibition of β-catenin signaling by nongenomic action of orphan nuclear receptor Nur77
Q35811338	Injury research in the genomic era.
Q24645231	Insig2 is associated with colon tumorigenesis and inhibits Bax-mediated apoptosis
Q35818443	Insights into the Molecular Pathogenesis of Activated B-Cell-like Diffuse Large B-Cell Lymphoma and Its Therapeutic Implications
Q34375924	Integrated modeling of clinical and gene expression information for personalized prediction of disease outcomes
Q51490388	Integrated profiling of diffuse large B-cell lymphoma with 7q gain.
Q35416193	Integrating biological knowledge with gene expression profiles for survival prediction of cancer
Q78512453	Integrating cytogenetics and gene expression profiling in the molecular analysis of multiple myeloma
Q30854282	Integrative clustering methods for high-dimensional molecular data
Q35170930	Interpreting the molecular biology and clinical behavior of multiple myeloma in the context of global gene expression profiling
Q36925740	Investigating the efficacy of nonlinear dimensionality reduction schemes in classifying gene and protein expression studies
Q35096214	Issues and progress with protein kinase inhibitors for cancer treatment
Q33412905	Iterative Bayesian Model Averaging: a method for the application of survival analysis to high-dimensional microarray data
Q35832755	Joint use of over- and under-sampling techniques and cross-validation for the development and assessment of prediction models
Q31044239	Kernel-based distance metric learning for microarray data classification
Q60502894	Knowledge-based neural networks for gene expression data analysis, modelling and profile discovery
Q24814110	L2L: a simple tool for discovering the hidden significance in microarray expression data
Q33648588	LMP1+SLAMF1high cells are associated with drug resistance in Epstein-Barr virus-positive Farage cells
Q44125775	Lack of prognostic significance of the germinal-center phenotype in diffuse large B-cell lymphoma patients treated with CHOP-like chemotherapy with and without rituximab
Q64916006	Large-Scale Automatic Feature Selection for Biomarker Discovery in High-Dimensional OMICs Data.
Q29615223	Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression
Q92236955	Learning misclassification costs for imbalanced classification on gene expression data
Q36059635	Lesional gene expression profiling in cutaneous T-cell lymphoma reveals natural clusters associated with disease outcome
Q33633714	Local-learning-based feature selection for high-dimensional data analysis
Q35634835	Looking beyond morphology: cancer gene expression profiling using DNA microarrays
Q37406798	Loss of HLA-DR expression and immunoblastic morphology predict adverse outcome in diffuse large B-cell lymphoma - analyses of cases from two prospective randomized clinical trials
Q41092345	Loss of HLA-DR expression is related to tumor microenvironment and predicts adverse outcome in diffuse large B-cell lymphoma
Q35978570	Loss of IRF8 Inhibits the Growth of Diffuse Large B-cell Lymphoma
Q38329996	Loss of expression of the adipocyte-type fatty acid-binding protein (A-FABP) is associated with progression of human urothelial carcinomas
Q35850018	Loss of major histocompatibility class II expression in non-immune-privileged site diffuse large B-cell lymphoma is highly coordinated and not due to chromosomal deletions.
Q37453629	Low GILT Expression is Associated with Poor Patient Survival in Diffuse Large B-Cell Lymphoma
Q34162187	Lymphoid malignancies: the dark side of B-cell differentiation
Q36959865	Lymphoma microenvironment: culprit or innocent?
Q28589356	M17, a gene specific for germinal center (GC) B cells and a prognostic marker for GC B-cell lymphomas, is dispensable for the GC reaction in mice
Q44544162	MAGE-A3 expression is an adverse prognostic factor in diffuse large B-cell lymphoma
Q63409870	MALT1 directs B cell receptor–induced canonical nuclear factor-κB signaling selectively to the c-Rel subunit
Q37470505	MET/PKCbeta expression correlate with metastasis and inhibition is synergistic in lung cancer
Q38233772	MYC-associated and double-hit lymphomas: a review of pathobiology, prognosis, and therapeutic approaches
Q63881018	Machine Learning Methods as a Tool for Predicting Risk of Illness Applying Next‐Generation Sequencing Data
Q98164806	Machine learning in oncology: a review
Q57175155	Maintenance Therapy in Diffuse Large B Cell Lymphoma and Mantle Cell Lymphoma
Q78581893	Mature T cell leukemias which cannot be adequately classified under the new WHO classification of lymphoid neoplasms
Q37743310	Maxdenominator Reweighted Sparse Representation for Tumor Classification
Q35967033	McTwo: a two-step feature selection algorithm based on maximal information coefficient
Q33928495	Mechanism-derived gene expression signatures and predictive biomarkers in clinical oncology
Q35010175	Medical applications of microarray technologies: a regulatory science perspective
Q31110581	Meta-analysis of gene expression data: a predictor-based approach
Q97525205	Metabolic Adaptations in Cancer Stem Cells
Q34008985	Metastasis of tumor cells is enhanced by downregulation of Bit1.
Q39218802	MicroRNA-21 regulates the sensitivity of diffuse large B-cell lymphoma cells to the CHOP chemotherapy regimen
Q24528253	Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer
Q36982175	Microarray analysis of gene expression of cancer to guide the use of chemotherapeutics
Q33320174	Microarray based diagnosis profits from better documentation of gene expression signatures
Q34044075	Microarray-based cancer prediction using single genes
Q37313817	Microarray-based cancer prediction using soft computing approach
Q38326709	Microarray-based classification of diffuse large B-cell lymphoma
Q24791738	Microarrays and molecular markers for tumor classification
Q34836984	Microarrays in pharmacogenomics--advances and future promise
Q36177378	Microarrays in veterinary diagnostics
Q36680069	Microarrays to identify new therapeutic strategies for cancer
Q38465717	Microbial forensics: predicting phenotypic characteristics and environmental conditions from large-scale gene expression profiles
Q64085609	Microbiome Learning Repo (ML Repo): A public repository of microbiome regression and classification tasks
Q35691640	Microvessel density and expression of vascular endothelial growth factor and its receptors in diffuse large B-cell lymphoma subtypes
Q36868498	Mining gene expression profiles: expression signatures as cancer phenotypes
Q36558011	Mitochondria in hematopoiesis and hematological diseases.
Q37061820	Mitogenic Effect of Orphan Receptor TR3 and Its Regulation by MEKK1 in Lung Cancer Cells
Q36344970	Mobile Genome Express (MGE): A comprehensive automatic genetic analyses pipeline with a mobile device
Q31112220	Model order selection for bio-molecular data clustering
Q51220498	Modified signal-to-noise: a new simple and practical gene filtering approach based on the concept of projective adaptive resonance theory (PART) filtering method.
Q37185837	Modulation of orphan nuclear receptor Nur77-mediated apoptotic pathway by acetylshikonin and analogues
Q34741163	Molecular cancer classification using a meta-sample-based regularized robust coding method
Q35102952	Molecular classification of parathyroid neoplasia by gene expression profiling
Q35670986	Molecular heterogeneity of diffuse large B-cell lymphoma: implications for disease management and prognosis
Q51075776	Molecular impact of selective NFKB1 and NFKB2 signaling on DLBCL phenotype.
Q35917589	Molecular medicine: a clinician's primer on microarrays.
Q84767205	Molecular pathogenesis of diffuse large B-cell lymphoma
Q38065892	Molecular pathology of lymphoma
Q35010198	Molecular portraits and the family tree of cancer
Q36381346	Molecular profiling reveals prognostically significant subtypes of canine lymphoma
Q36168697	Molecular prognostic factors in diffuse large B-cell lymphoma
Q79934103	Molecular signatures in biopsy specimens of lung cancer
Q36007355	Molecular signatures of lymphoma
Q36239669	Monoclonal antibody therapy of leukaemias and lymphomas
Q38179500	Moving beyond rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone for diffuse large B-cell lymphoma
Q99607473	Multi-scale supervised clustering-based feature selection for tumor classification and identification of biomarkers and targets on genomic data
Q30763386	Multi-task feature selection in microarray data by binary integer programming
Q24793866	Multiclass classification of microarray data with repeated measurements: application to cancer
Q35747661	Multicolor-FICTION: expanding the possibilities of combined morphologic, immunophenotypic, and genetic single cell analyses
Q35755485	Multiparameter analysis of homogeneously R-CHOP-treated diffuse large B cell lymphomas identifies CD5 and FOXP1 as relevant prognostic biomarkers: report of the prospective SAKK 38/07 study.
Q47445559	Multiple fuzzy neural network system for outcome prediction and classification of 220 lymphoma patients on the basis of molecular profiling
Q39753010	Multiplex polymerase chain reaction-based prognostic models in diffuse large B-cell lymphoma patients treated with R-CHOP.
Q40438326	Multiplex reverse transcription-polymerase chain reaction combined with on-chip electrophoresis as a rapid screening tool for candidate gene sets
Q36447932	Mutations in the DNA-binding codons of TP53, which are associated with decreased expression of TRAILreceptor-2, predict for poor survival in diffuse large B-cell lymphoma
Q37638021	NEK2 induces drug resistance mainly through activation of efflux drug pumps and is associated with poor prognosis in myeloma and other cancers
Q35586784	Neoadjuvant comparisons of aromatase inhibitors and tamoxifen: pretreatment determinants of response and on-treatment effect
Q89926626	Network modeling of patients' biomolecular profiles for clinical phenotype/outcome prediction
Q34427904	Network-based Prediction of Cancer under Genetic Storm
Q24796756	Neural network analysis of lymphoma microarray data: prognosis and diagnosis near-perfect
Q31122605	New insights into ADPKD molecular pathways using combination of SAGE and microarray technologies
Q91276848	New machine-learning technologies for computer-aided diagnosis
Q35063883	New molecular methods for classification, diagnosis and therapy prediction of hematological malignancies
Q37918027	New strategies in diffuse large B-cell lymphoma: translating findings from gene expression analyses into clinical practice
Q26796428	Next-generation prognostic assessment for diffuse large B-cell lymphoma
Q37457207	Nodal diffuse large B-cell lymphomas in children and adolescents: immunohistochemical expression patterns and c-MYC translocation in relation to clinical outcome
Q44228664	Non-Hodgkin's lymphoma in the microarray era.
Q34328089	Non-invasive mapping of the gastrointestinal microbiota identifies children with inflammatory bowel disease
Q40863355	Non-negative matrix factorization by maximizing correntropy for cancer clustering
Q37858532	Novel agents for diffuse large B-cell lymphoma
Q36616528	Novel approaches for the management of patients with Ewing sarcoma
Q37775632	Novel disease targets and management approaches for diffuse large B-cell lymphoma
Q31028064	Novel prognostic genes of diffuse large B-cell lymphoma revealed by survival analysis of gene expression data
Q36871990	Novel therapeutic targets in mantle cell lymphoma
Q35111768	Novel therapeutics for aggressive non-Hodgkin's lymphoma
Q36429727	Novel treatment strategies for aggressive non-Hodgkin's lymphoma
Q59117821	On Feature Selection and Rule Extraction for High Dimensional Data: A Case of Diffuse Large B-Cell Lymphomas Microarrays Classification
Q24645617	Onco-miR-155 targets SHIP1 to promote TNFalpha-dependent growth of B cell lymphomas
Q37295261	Oncologist's/haematologist's view on the roles of pathologists for molecular targeted cancer therapy
Q54364450	Open-label, single-arm, phase II study of enzastaurin in patients with follicular lymphoma.
Q35008943	Optimal gene expression analysis by microarrays
Q33822080	Optimization based tumor classification from microarray gene expression data.
Q44394901	Optimization of quantitative real-time RT-PCR parameters for the study of lymphoid malignancies
Q30749830	Options available--from start to finish--for obtaining data from DNA microarrays II.
Q33551720	Overexpression of an activated REL mutant enhances the transformed state of the human B-lymphoma BJAB cell line and alters its gene expression profile
Q37940364	Overview of microarrays in drug discovery and development
Q37644833	PATZ1 expression correlates positively with BAX and negatively with BCL6 and survival in human diffuse large B cell lymphomas
Q38996724	PD-1-PD-L1 immune-checkpoint blockade in B-cell lymphomas
Q43462759	PKC-beta II expression has prognostic impact in nodal diffuse large B-cell lymphoma
Q28509628	PKC-beta controls I kappa B kinase lipid raft recruitment and activation in response to BCR signaling
Q38323206	PROX1 overexpression inhibits protein kinase C beta II transcription through promoter DNA methylation
Q36713498	Paraffin-based 6-gene model predicts outcome in diffuse large B-cell lymphoma patients treated with R-CHOP.
Q37403682	Pathophysiology of retinal lymphoma
Q34721895	Pathway activity inference for multiclass disease classification through a mathematical programming optimisation framework
Q44564603	Patients with high-risk aggressive lymphoma treated with frontline intensive chemotherapy and autografting: evidence of marked differences in outcome between patients with age-adjusted International Prognostic Index scores 2 and 3.
Q38127385	Pediatric lymphoma diagnosis: role of FNAC, biopsy, immunohistochemistry and molecular diagnostics
Q34695697	Pharmacogenomic strategies provide a rational approach to the treatment of cisplatin-resistant patients with advanced cancer
Q42115619	Pharmacological manipulation of Bcl-2 family members to control cell death
Q37554503	Phospho-p70S6K and cdc2/cdk1 as therapeutic targets for diffuse large B-cell lymphoma
Q38984735	Phosphodiesterase 4 inhibitors have wide-ranging activity in B-cell malignancies
Q30759423	Pitfalls in the use of DNA microarray data for diagnostic and prognostic classification
Q85804046	Precision treatment of distinct molecular subtypes of diffuse large B-cell lymphoma: ascribing treatment based on the molecular phenotype
Q64085970	Predicting Complete Remission of Acute Myeloid Leukemia: Machine Learning Applied to Gene Expression
Q45728735	Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning
Q36780164	Predicting the outcome in non-Hodgkin lymphoma with molecular markers
Q30578215	Predicting the survival time for diffuse large B-cell lymphoma using microarray data
Q35153794	Prediction of survival in diffuse large B-cell lymphoma based on the expression of 2 genes reflecting tumor and microenvironment
Q31134364	Prediction potential of candidate biomarker sets identified and validated on gene expression data from multiple datasets.
Q40109282	Predictive tests for individualization of pharmacological cancer treatment
Q38872027	Presence of simian virus 40 in diffuse large B-cell lymphomas in Tunisia correlates with germinal center B-cell immunophenotype, t(14;18) translocation, and P53 accumulation
Q33598987	Primary diffuse large B-cell lymphoma of the oral cavity: germinal center classification
Q35089389	Profiling cancer
Q47738329	Prognosis of localized diffuse large B-cell lymphoma in younger patients
Q92885779	Prognostic Nomogram for Overall Survival in Patients with Diffuse Large B-Cell Lymphoma
Q36244809	Prognostic efficacy of the human B-cell lymphoma prognostic genes in predicting disease-free survival (DFS) in the canine counterpart
Q35548353	Prognostic factors and risk-based therapy in pediatric acute myeloid leukemia
Q34882773	Prognostic factors for diffuse large B-cell lymphoma in the R(X)CHOP era.
Q37635115	Prognostic immunophenotypic biomarker studies in diffuse large B cell lymphoma with special emphasis on rational determination of cut-off scores.
Q43146817	Prognostic impact of protein kinase C beta II expression in R-CHOP-treated diffuse large B-cell lymphoma patients
Q35587065	Prognostic significance of CD44 expression in diffuse large B cell lymphoma of activated and germinal centre B cell-like types: a tissue microarray analysis of 90 cases
Q43248488	Prognostic significance of S-phase kinase-associated protein 2 and p27kip1 in patients with diffuse large B-cell lymphoma: effects of rituximab
Q37706051	Prognostic value of expression of nuclear factor kappa-B/p65 in non-GCB DLBCL patients.
Q37833087	Prognostication of diffuse large B-cell lymphoma in the rituximab era.
Q35824980	Progress in myeloma stem cells
Q73401113	Progressive disease following autologous transplantation in patients with chemosensitive relapsed or primary refractory Hodgkin's disease or aggressive non-Hodgkin's lymphoma
Q79270324	Promoter hypermethylation of the DNA-repair gene O6-methylguanine-DNA methyltransferase and p53 mutation in diffuse large B-cell lymphoma
Q80413450	Proof concept for clinical justification of network mapping for personalized cancer therapeutics
Q35833866	Pros and cons of microarray technology in allergy research
Q42807725	Protein expression and cellular localization in two prognostic subgroups of diffuse large B-cell lymphoma: higher expression of ZAP70 and PKC-beta II in the non-germinal center group and poor survival in patients deficient in nuclear PTEN.
Q37020881	Protein kinase C beta in malignant pleural mesothelioma
Q43275999	Protein kinase C-beta II expression in diffuse large B-cell lymphoma predicts for inferior outcome of anthracycline-based chemotherapy with and without rituximab
Q35634280	Protein kinase C-beta inhibition induces apoptosis and inhibits cell cycle progression in acquired immunodeficiency syndrome-related non-hodgkin lymphoma cells
Q41971372	Protein kinase C: an attractive target for cancer therapy.
Q33569854	Protein kinase Cbeta modulates ligand-induced cell surface death receptor accumulation: a mechanistic basis for enzastaurin-death ligand synergy.
Q33197095	Proteomic analysis of pulmonary edema fluid and plasma in patients with acute lung injury.
Q35725628	Proteomics and the haematologist.
Q37696313	Protocol for qRT-PCR analysis from formalin fixed paraffin embedded tissue sections from diffuse large b-cell lymphoma: Validation of the six-gene predictor score.
Q36757502	Quantitative image analysis in the assessment of diffuse large B-cell lymphoma
Q38430790	Quantitative nuclease protection assay in paraffin-embedded tissue replicates prognostic microarray gene expression in diffuse large-B-cell lymphoma
Q38699741	RGIFE: a ranked guided iterative feature elimination heuristic for the identification of biomarkers
Q42376068	RIFS: a randomly restarted incremental feature selection algorithm.
Q33357619	RNA expression analysis from formalin fixed paraffin embedded tissues
Q57277018	RNA expression analysis of formalin-fixed paraffin-embedded tumors
Q33941314	RNA: state memory and mediator of cellular phenotype
Q28397762	Random generalized linear model: a highly accurate and interpretable ensemble predictor
Q28834535	Rapid Prediction of Bacterial Heterotrophic Fluxomics Using Machine Learning and Constraint Programming
Q39982575	Ratio adjustment and calibration scheme for gene-wise normalization to enhance microarray inter-study prediction
Q37234623	Rational combined targeting of phosphodiesterase 4B and SYK in DLBCL
Q36150374	Recent advances in the molecular diagnosis of diffuse large B-cell lymphoma
Q34487811	Regulation of Nur77 nuclear export by c-Jun N-terminal kinase and Akt.
Q38210641	Relapsed/refractory diffuse large B-cell lymphoma: review of the management of transplant-eligible patients
Q24289394	Reliability and reproducibility issues in DNA microarray measurements
Q90077233	Remaining challenges in predicting patient outcomes for diffuse large B-cell lymphoma
Q28131820	Repeated observation of breast tumor subtypes in independent gene expression data sets
Q39938060	Results of a multicentre UK-wide retrospective study evaluating the efficacy of pixantrone in relapsed, refractory diffuse large B cell lymphoma
Q35750976	Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents
Q37598771	Retinoid X receptor regulates Nur77/TR3-dependent apoptosis [corrected] by modulating its nuclear export and mitochondrial targeting
Q35652930	Retrospective analysis of protein kinase C-beta (PKC-beta) expression in lymphoid malignancies and its association with survival in diffuse large B-cell lymphomas
Q34308389	Revisiting global gene expression analysis
Q35499320	Risk Factors of Non-Hodgkin Lymphoma
Q33407974	Robust methods for accurate diagnosis using pan-microbiological oligonucleotide microarrays
Q35740262	Robust two-gene classifiers for cancer prediction
Q40496898	Role of CD21 antigen in diffuse large B-cell lymphoma and its clinical significance
Q33256872	Role of ancillary techniques in diagnosing and subclassifying non-Hodgkin's lymphomas on fine needle aspiration cytology
Q55717558	Role of microarray in cancer diagnosis.
Q30605582	SMOTE for high-dimensional class-imbalanced data
Q24295903	STAT5 represses BCL6 expression by binding to a regulatory region frequently mutated in lymphomas
Q39472422	Safety and Pharmacodynamics of the PDE4 Inhibitor Roflumilast in Advanced B-cell Malignancies
Q48458182	Safety, tolerability, QTc evaluation, and pharmacokinetics of single and multiple doses of enzastaurin HCl (LY317615), a protein kinase C-beta inhibitor, in healthy subjects.
Q51335591	Selection of causal gene sets for lymphoma prognostication from expression profiling and construction of prognostic fuzzy neural network models.
Q35098956	Selective model averaging with bayesian rule learning for predictive biomedicine
Q24804682	Semi-supervised methods to predict patient survival from gene expression data
Q36471600	Semiautomated multiplexed quantum dot-based in situ hybridization and spectral deconvolution
Q33312689	Serum diagnosis of diffuse large B-cell lymphomas and further identification of response to therapy using SELDI-TOF-MS and tree analysis patterning
Q86022539	Serum profiling by mass spectrometry combined with bioinformatics for the biomarkers discovery in diffuse large B-cell lymphoma
Q91579802	ShinyLearner: A containerized benchmarking tool for machine-learning classification of tabular data
Q37829224	Signal transduction inhibitor therapy for lymphoma
Q35666703	Signaling in transitional type 2 B cells is critical for peripheral B-cell development
Q38150876	Signaling pathways in lymphoma: pathogenesis and therapeutic targets
Q41735339	Simple decision rules for classifying human cancers from gene expression profiles
Q34777109	Sparse logistic regression with a L1/2 penalty for gene selection in cancer classification
Q33419874	Sparse representation for classification of tumors using gene expression data
Q37616792	Sparse representation for tumor classification based on feature extraction using latent low-rank representation.
Q51806652	Spontaneous high-titered IgG antibody responses against BCL-2 in patients with aggressive lymphomas.
Q35518656	Sputnik: ad hoc distributed computation.
Q89751386	State-of-the-Art Machine Learning Techniques Aiming to Improve Patient Outcomes Pertaining to the Cardiovascular System
Q24678378	Statistical analysis of an RNA titration series evaluates microarray precision and sensitivity on a whole-array basis
Q37284250	Statistical challenges in preprocessing in microarray experiments in cancer
Q35789866	Statistical considerations for immunohistochemistry panel development after gene expression profiling of human cancers
Q35984039	Structured feature selection using coordinate descent optimization.
Q44704125	Studies of the potential utility of Ki67 as a predictive molecular marker of clinical response in primary breast cancer
Q35080295	Study of suboptimum treatment response: lessons from breast cancer
Q31137364	Subclass mapping: identifying common subtypes in independent disease data sets
Q37179385	Subgraph augmented non-negative tensor factorization (SANTF) for modeling clinical narrative text
Q39375022	Super-SILAC allows classification of diffuse large B-cell lymphoma subtypes by their protein expression profiles
Q31043807	Support vector machines for dyadic data
Q33259095	Suppression of Mcl-1 via RNA interference sensitizes human hepatocellular carcinoma cells towards apoptosis induction.
Q42702972	Surface-antigen expression profiling of B cell chronic lymphocytic leukemia: from the signature of specific disease subsets to the identification of markers with prognostic relevance
Q58776059	Survival associated alternative splicing events in diffuse large B-cell lymphoma
Q44864120	Survival prediction of diffuse large-B-cell lymphoma based on both clinical and gene expression information
Q47300115	Synergistic targeting of the regulatory and catalytic subunits of PI3Kδ in mature B cell malignancies
Q24298072	TLE1 is an anoikis regulator and is downregulated by Bit1 in breast cancer cells
Q89867359	TMEM30A loss-of-function mutations drive lymphomagenesis and confer therapeutically exploitable vulnerability in B-cell lymphoma
Q41908005	TSG: a new algorithm for binary and multi-class cancer classification and informative genes selection
Q37766121	Targeted treatment and new agents in diffuse large B cell lymphoma
Q34588195	Targeting Nur77 translocation
Q35628888	Targeting PKC in multiple myeloma: in vitro and in vivo effects of the novel, orally available small-molecule inhibitor enzastaurin (LY317615.HCl).
Q38184819	The 'omics' of adrenocortical tumours for personalized medicine.
Q36812744	The Influence of the Global Gene Expression Shift on Downstream Analyses
Q41909242	The Role of mTOR Inhibitors for the Treatment of B-Cell Lymphomas
Q34622215	The SUV and FLT PET: a tasty alphabet soup or a dog's breakfast?
Q34956078	The T-cell response in patients with cancer
Q91658641	The Unsolved Puzzle of c-Rel in B Cell Lymphoma
Q53153100	The absolute monocyte and lymphocyte prognostic score predicts survival and identifies high-risk patients in diffuse large-B-cell lymphoma.
Q27681982	The ansamycin antibiotic, rifamycin SV, inhibits BCL6 transcriptional repression and forms a complex with the BCL6-BTB/POZ domain
Q34313320	The biology of human lymphoid malignancies revealed by gene expression profiling.
Q53258385	The burden of scientific progress: growing inequalities in the delivery of cancer care.
Q28241767	The c-Rel transcription factor and B-cell proliferation: a deal with the devil
Q35122837	The classification of lymphomas: a new beginning or the end of an era?
Q46796219	The contribution of HGAL/GCET2 in immunohistological algorithms: a comparative study in 424 cases of nodal diffuse large B-cell lymphoma
Q33490384	The derivation of diagnostic markers of chronic myeloid leukemia progression from microarray data
Q54643114	The differential expression of Galectin-1 and Galectin-3 in normal lymphoid tissue and non-Hodgkin's and Hodgkin's lymphomas.
Q37174123	The expression of 16 genes related to the cell of origin and immune response predicts survival in elderly patients with diffuse large B-cell lymphoma treated with CHOP and rituximab.
Q53222182	The expression of anamorsin in diffuse large B cell lymphoma: possible prognostic biomarker for low IPI patients.
Q35821001	The expression of the aurora-A gene and its significance with tumorgenesis in non-Hodgkin's lymphoma
Q36331576	The feasibility of gene expression profiling generated in fine-needle aspiration specimens from patients with follicular lymphoma and diffuse large B-cell lymphoma
Q39566639	The gene expression profile of unstimulated dendritic cells can be used as a predictor of function.
Q36280547	The histological and biological spectrum of diffuse large B-cell lymphoma in the World Health Organization classification
Q33268949	The impact of sample imbalance on identifying differentially expressed genes.
Q77476882	The microarray way to tailored cancer treatment
Q37815142	The molecular background of aggressive B cell lymphomas as a basis for targeted therapy
Q36939043	The molecular characterization and clinical management of multiple myeloma in the post-genome era.
Q34530992	The molecular classification of multiple myeloma
Q39986126	The oral protein-kinase C beta inhibitor enzastaurin (LY317615) suppresses signalling through the AKT pathway, inhibits proliferation and induces apoptosis in multiple myeloma cell lines.
Q33495401	The ordering of expression among a few genes can provide simple cancer biomarkers and signal BRCA1 mutations
Q36120552	The parameter sensitivity of random forests
Q34371078	The pre-B-cell receptor associated protein VpreB3 is a useful diagnostic marker for identifying c-MYC translocated lymphomas
Q34688223	The promise of biomarkers in cancer screening and detection
Q36670881	The role of angiogenesis in human non-Hodgkin lymphomas
Q39102576	The serine-threonine kinase p90RSK is a new target of enzastaurin in follicular lymphoma cells
Q34047455	The significance of FOXP1 in diffuse large B-cell lymphoma
Q48027386	The therapeutic effect of rituximab on CD5-positive and CD5-negative diffuse large B-cell lymphoma
Q36964732	The therapeutic role of targeting protein kinase C in solid and hematologic malignancies
Q34411134	The top-scoring 'N' algorithm: a generalized relative expression classification method from small numbers of biomolecules
Q36169994	The transcriptome's drugable frequenters
Q35188517	The use of genetic microarray analysis to classify and predict prognosis in haematological malignancies.
Q36773687	The use of transcriptomic biomarkers for personalized medicine
Q74308249	The value of microarray techniques for quantitative gene profiling in molecular diagnostics
Q53368295	Tissue microarrays in diffuse large B-cell lymphomas: are they really able to identify distinct prognostic groups in lymphomas of both nodal and extranodal origin?
Q37385810	Toward a systems biology approach to investigate cellular networks in normal and malignant B cells
Q42696739	Towards Clinically More Relevant Dissection of Patient Heterogeneity via Survival based Bayesian Clustering
Q35569564	Towards molecular diagnosis and targeted therapy of lymphoid malignancies
Q24554209	Transcriptional analysis of the B cell germinal center reaction
Q42320170	Transcriptional mechanism of vascular endothelial growth factor-induced expression of protein kinase CβII in chronic lymphocytic leukaemia cells.
Q34387585	Transcriptional profiling of a mouse model for Rett syndrome reveals subtle transcriptional changes in the brain
Q27939633	Transcriptional response of Saccharomyces cerevisiae to DNA-damaging agents does not identify the genes that protect against these agents
Q35129723	Transducing signals from antigen receptors to nuclear factor kappaB.
Q31062604	Translating microarray data for diagnostic testing in childhood leukaemia
Q27006062	Treatment of diffuse large B cell lymphoma
Q28290155	Tumor cell-mediated induction of the stromal factor stromelysin-3 requires heterotypic cell contact-dependent activation of specific protein kinase C isoforms
Q33642188	Tumor-specific and proliferation-specific gene expression typifies murine transgenic B cell lymphomagenesis.
Q39965971	Tyrosine kinase inhibition in diffuse large B-cell lymphoma: molecular basis for antitumor activity and drug resistance of dasatinib.
Q33299950	Unravelling the hidden heterogeneities of diffuse large B-cell lymphoma based on coupled two-way clustering
Q37705417	Unresolved issues in diffuse large B-cell lymphomas
Q36269919	Update on lymphoma management: diffuse large B-cell NHL.
Q38888510	Upregulation of long noncoding RNA PEG10 associates with poor prognosis in diffuse large B cell lymphoma with facilitating tumorigenicity
Q47392520	Use of Expression Analysis to Predict Outcome After Radical Prostatectomy
Q30992230	Use of extreme patient samples for outcome prediction from gene expression data.
Q33196034	Use of proteomic analysis to monitor responses to biological therapies
Q35543889	Using DNA microarrays for diagnostic and prognostic prediction
Q47971165	Using Gene Expression Ratios to Predict Outcome Among Patients With Mesothelioma
Q28386273	Using rule-based machine learning for candidate disease gene prioritization and sample classification of cancer gene expression data
Q36743357	Using the information embedded in the testing sample to break the limits caused by the small sample size in microarray-based classification
Q37293519	Utility of subsequent conventional dose chemotherapy in relapsed/refractory transplant-eligible patients with diffuse large B-cell lymphoma failing platinum-based salvage chemotherapy.
Q36741637	Utilization of pathway signatures to reveal distinct types of B lymphoma in the Emicro-myc model and human diffuse large B-cell lymphoma
Q34646755	Utilization of the Eμ-Myc mouse to model heterogeneity of therapeutic response
Q47373475	VEGF121, is predictor for survival in activated B-cell-like diffuse large B-cell lymphoma and is related to an immune response gene signature conserved in cancers
Q36194645	Validation of tissue microarray immunohistochemistry staining and interpretation in diffuse large B-cell lymphoma
Q51897815	Variable selection in penalized model-based clustering via regularization on grouped parameters.
Q33369633	Very Important Pool (VIP) genes--an application for microarray-based molecular signatures
Q31116629	Visualization-based cancer microarray data classification analysis
Q36168226	Wealth of opportunity - the C1 domain as a target for drug development
Q34032697	Weighted Area Under the Receiver Operating Characteristic Curve and Its Application to Gene Selection
Q37316548	Why does cytotoxic chemotherapy cure only some cancers?
Q53362281	[The genetics of glioma: molecular classification].
Q34958884	c-Myc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia/lymphoma
Q36088278	cDNA microarrays: revolutionary technology for the diagnosis, prognosis, and treatment of cutaneous T-cell lymphoma
Q36152713	hemaClass.org: Online One-By-One Microarray Normalization and Classification of Hematological Cancers for Precision Medicine
Q35863651	iRDA: a new filter towards predictive, stable, and enriched candidate genes
Q36558001	p53 and Nur77/TR3 - transcription factors that directly target mitochondria for cell death induction

P6179	Dimensions Publication ID	1042502685
P356	DOI	10.1038/NM0102-68
P8608	Fatcat ID	release_7aer4mld6zbgxiyftry4xzob7m
P3181	OpenCitations bibliographic resource ID	789511
P698	PubMed publication ID	11786909
P5875	ResearchGate publication ID	11571355

P50	author	Eric Lander	Q970550
		Todd Golub	Q7812388
		Jill P. Mesirov	Q19664665
		Michelle Gaasenbeek	Q28914670
		Pablo Tamayo	Q59551108
		Margaret A Shipp	Q89030667
		Geraldine Pinkus	Q110078288
P2093	author name string	Jeffery L Kutok
		Jon C Aster
		Donna S Neuberg
		T Andrew Lister
		Ricardo C T Aguiar
		Andrew Norton
		Michael Reich
		Andrew P Weng
		Michael Angelo
		Ken N Ross
		Kim W Last
		Margaret A Koval
		Tane S Ray
P2860	cites work	Structural basis of BFL-1 for its interaction with BAX and its anti-apoptotic action in mammalian and yeast cells	Q22253852
		The human PD-1 gene: complete cDNA, genomic organization, and developmentally regulated expression in B cell progenitors	Q24318487
		A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma	Q24322614
		The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-kappaB that blocks TNFalpha-induced apoptosis	Q24608044
		Cluster analysis and display of genome-wide expression patterns	Q24644463
		NF-kappaB-mediated up-regulation of Bcl-x and Bfl-1/A1 is required for CD40 survival signaling in B lymphocytes	Q24685661
		Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling	Q27860529
		Molecular classification of cancer: class discovery and class prediction by gene expression monitoring	Q27861072
		Apoptosis of T cells mediated by Ca2+-induced release of the transcription factor MEF2	Q28146018
		A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project	Q28251216
		A death-domain-containing receptor that mediates apoptosis	Q28297670
		Immunodeficiency in protein kinase cbeta-deficient mice	Q28616043
		Interpreting patterns of gene expression with self-organizing maps: methods and application to hematopoietic differentiation	Q29616072
		International Consensus Conference on High-Dose Therapy with Hematopoietic Stem Cell Transplantation in Aggressive Non-Hodgkin's Lymphomas: report of the jury	Q33718107
		Cellular origin of human B-cell lymphomas.	Q33772424
		Signal transduction via CD44: role of plasma membrane microdomains	Q33803238
		The cAMP signaling pathway as a therapeutic target in lymphoid malignancies.	Q33865914
		Cytochrome c release and apoptosis induced by mitochondrial targeting of nuclear orphan receptor TR3.	Q33914401
		HMG-I/Y, a new c-Myc target gene and potential oncogene	Q33964722
		A role for the Tec family tyrosine kinase Txk in T cell activation and thymocyte selection	Q35514734
		Nur77 transcription activity correlates with its apoptotic function in vivo	Q41701543
		Suppression of human inflammatory cell function by subtype-selective PDE4 inhibitors correlates with inhibition of PDE4A and PDE4B.	Q42117582
		Expression of the adhesion molecule ICAM-1 in non-Hodgkin's lymphoma: relationship with tumor dissemination and prognostic importance	Q44654145
		Enzymatic rationale and preclinical support for a potent protein kinase C beta inhibitor in cancer therapy	Q48122829
		Clustering of extensive somatic mutations in the variable region of an immunoglobulin heavy chain gene from a human B cell lymphoma	Q48369391
		Frequent disruption of the RB1 pathway in diffuse large B cell lymphoma: prognostic significance of E2F-1 and p16INK4A.	Q52539190
		Galectin-3 overexpression protects from apoptosis by improving cell adhesion properties	Q63413190
		The CD69 receptor: a multipurpose cell-surface trigger for hematopoietic cells	Q72768300
		Positive and negative thymic selection in T cell receptor-transgenic mice correlate with Nur77 mRNA expression	Q73691807
		Apoptosis. Mitochondria--the death signal integrators	Q74257381
P433	issue	1
P407	language of work or name	English	Q1860
P921	main subject	machine learning	Q2539
		diffuse large B-cell lymphoma	Q2626074
		B-cell lymphoma	Q4833719
P304	page(s)	68-74
P577	publication date	2002-01-01
P1433	published in	Nature Medicine	Q1633234
P1476	title	Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning
P478	volume	8

Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning

scientific article (publication date: 2002)

Reverse relations